Integrative analysis of miRNA-mRNA network in idiopathic membranous nephropathy by bioinformatics analysis

Wenfang He1,2, Jinshi Zhang2, Shizhu Yuan2

  • 1Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Anhui, China.

Peerj
|October 27, 2021
PubMed
Abstract

Insights

This study identifies two key microRNA-messenger RNA pairs, miR-155-5p-FOS and miR-146a-5p-BTG2, involved in idiopathic membranous nephropathy (IMN) pathogenesis and immune processes for improved diagnosis and treatment.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Idiopathic membranous nephropathy (IMN) is associated with specific antigens like PLA2R1, THSD7A, and NELL-1.
  • The precise pathomechanisms underlying IMN remain incompletely understood.
  • Clarifying IMN mechanisms is crucial for advancing diagnostic and therapeutic strategies.

Purpose of the Study:

  • To investigate the role of microRNA (miRNA) regulatory networks in IMN development.
  • To identify differentially expressed miRNAs and messenger RNAs (mRNAs) in IMN patients.
  • To discover potential diagnostic biomarkers and therapeutic targets for IMN.

Main Methods:

  • Construction of miRNA-mRNA regulatory networks using bioinformatics tools.
  • Differential expression analysis of miRNAs and mRNAs in IMN patients versus controls.
  • Pathway and functional enrichment analyses (KEGG, GO), immune gene screening, and protein-protein interaction network construction.

Main Results:

  • Two significant miRNA-mRNA pairs, miR-155-5p-FOS and miR-146a-5p-BTG2, were identified as differentially expressed in IMN.
  • These identified pairs are implicated in immune-related processes contributing to IMN.
  • Preliminary validation of 10 miRNAs and 10 genes was performed using a validation dataset.

Conclusions:

  • The identified miRNA-mRNA pairs, particularly miR-155-5p-FOS and miR-146a-5p-BTG2, show potential as diagnostic markers for IMN.
  • These pairs may represent novel therapeutic targets for managing IMN.
  • Further research into these molecular interactions can enhance IMN diagnosis and treatment strategies.